Recent News

• 03.25.2026 - QT Imaging Reports 2025 Fourth Quarter and Full Year Financial Results
• 03.24.2026 - QT Imaging Receives UAE Regulatory Clearance
• 03.18.2026 - QT Imaging to Hold 2025 Fourth Quarter and Full Year Conference Call on March 25, 2026
• 03.10.2026 - QT Imaging Receives FDA Clearance for Its Breast Acoustic CT Scanner Enhanced Configuration to Improve Posterior Breast Imaging Coverage
• 03.04.2026 - QT Imaging Names Renowned Breast Cancer Researcher Dr. Mary Yamashita as Medical Advisor
• 02.23.2026 - QT Imaging Achieves Major Reimbursement Milestone with AMA Category III CPT Code for 3D Breast Ultrasound Tomography
• 02.18.2026 - QT Imaging Reports Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results
• 02.03.2026 - QT Imaging Announces Presentation at SPIE Medical Imaging 2026
• 01.27.2026 - QT Imaging Announces Uplisting to Nasdaq
• 01.27.2026 - QT Imaging Announces Collaboration with Olea Medical to Advance Visualization and Quantitative Analytics for Its Cloud Imaging Platform

Recent Filings

• 02.25.2026 - EX-99.1 EX-99.1
• 02.25.2026 - 8-K Current report
• 02.18.2026 - EX-99.1 EX-99.1
• 02.18.2026 - 8-K Current report
• 02.17.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.17.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.06.2026 - 8-K Current report
• 02.06.2026 - EX-99.1 EX-99.1
• 02.02.2026 - S-8 Securities to be offered to employees in employee benefit plans
• 01.29.2026 - 424B3 Prospectus [Rule 424(b)(3)]